PDF and Forms Management
Archived on February 17, 2026. Original response deadline: . Full description on SAM.gov.
Description
The Program Management Office (PMO) for the DISA Joint Enterprise Licensing Agreement
(JELA) is conducting market research to identify available capabilities for commercial IT
software solutions. This RFI aims to gather information on available licensing for software in the
functional areas of Portable Document Format (PDF) and Forms Management.
DISA is seeking information for a solution that must be architected for a multi-agency enterprise
environment with the demonstrated scalability to support approximately two million users. It
must be a support model capable of delivering services across multiple DoW agencies with
technical capability focusing on two areas:
1. PDF Software solutions that provide comprehensive capabilities for the creation,
management, and manipulation of PDF documents.
2. Forms Management solutions that provide robust capabilities across the entire form
lifecycle. This includes the design and creation of complex, multi-page documents,
seamless web integration, and deployment to various platforms. Solutions must feature
dynamic, adaptive forms that move beyond static PDFs, offering interactive experiences
through scripting.
Furthermore, all solutions must ensure Section 508 compliance, provide mobile accessibility, and
deliver mission-critical analytics.
Overview
Award Overview
Possible prior contracts
Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Showing 1 of 1 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Sources Sought | DEFENSE INFORMATION SYSTEMS AGENCY (DISA) | Jan 16, 2026 | 198.1 KB |
Lifecycle
842673739- Market Research
Pre-solicitation or formal solicitation typically follows within 30–180 days. (estimate)
- Market ResearchCurrentJan 16, 2026
PDF and Forms Management
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
Johns Hopkins University Applied Physics Laboratory (JHU/APL) University Affiliated Research Center (UARC) Support Services | Awarded | 541715 | No Set-Aside | 10/19/2026 | Open | Laurel, MD | |
See attached Justification and Approval document for description. | Sole Source / J&A | - | No Set-Aside | 10/19/2026 | Open | - | |
Combine Synopsis/Solicitation # HT940627QE003 is issued as a Request for Quote (RFQ). The combined synopsis/solicitation document and incorporated provisions and clauses are those in effect through the Federal Acquisition Regulation as indicated in the attachment. DD Form 1449 is being utilized to generate applicable clauses from the Standard Procurement System. The Defense Health Agency, Healthcare Contracting Division- Southeast intends to procure a FIRM-FIXED price contract in support of Navy Medical Center Camp Lejeune, NC. The contractor shall provide full-service maintenance for Zeiss MediTec equipment, including PMs, repair services, and software updates. Services shall be performed in accordance with the manufacturer’s recommendations and applicable medical equipment service standards. Provide regularly scheduled preventative maintenance (PM) on all covered Zeiss MediTec equipment. Ensure timely onsite repair and return to service of any malfunctioning equipment. Perform required software updates in accordance with manufacturer guidance. This requirement is being solicited in accordance with Federal Acquisition Regulation FAR Part 12.6; Streamlined Procedures for Evaluation and Solicitation for Commercial Products and Commercial Services. Competition Approach: Small Business set-aside North American Industrial Classification System (NAICS): The associated NAICS code for this procurement is 811210, with a small business size standard of $34.0M. Submission of Quotes: Offerors must follow the requirements of FAR 52.212-1, Addendum to 52.212-1, FAR 52.212-2, and Addendum to 52.212-2. Submission MUST include Volume I and Volume II. | Solicitation | 811210 | Total Small Business Set-Aside | 10/19/2026 | 10/29/2026 | Camp Lejeune, NC | |
See Soliciation Amendment 0001. USAISR's Combat Casualty Care Research Team 1 (CRT-1) requires resupply of its Blood Donor Room on a reoccurring basis in order to satisfy research requirements for blood collection. USAISR currently has three Terumo Trima Accel Blood Collection Systems in operation. These units support numerous research protocols. Various collection sets are used to collect a variety of blood products from donors. The Trima instrument is FDA-approved, but only with the use of original manufacturer-supplied consumable products. These consumables are specific to the instrument and there are no generic substitute products available in the marketplace. Please note - This is a 100% ser-aside for Service-Disabled Veteran-Owned Small Businesses. See attached complete solicitation for all requirement details and instructions to offerors. | Solicitation | 325413 | Service-Disabled Veteran-Owned Small Business Set-Aside | 10/19/2026 | 10/29/2026 | 0, TX | |
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product. The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022. NOTE: Another amendment will be posted which will include Offeror questions and Government responses. (Amendment 0002 only extends the proposal due date). | Solicitation | 541715 | No Set-Aside | 10/19/2026 | 11/06/2026 | 28360, MD |
Additional Details
Solicitation Number
842673739
Archive Date
Feb 17, 2026
Office Address
SCOTT AFB, IL, 62225-5406